FLGT

Fulgent Genetics logo

Fulgent Genetics, Inc. (NASDAQ: FLGT) COO sells $23,557.15 in stock

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Rating) COO Jian Xie sold 685 shares of the company in a trade dated Wednesday, November 30. The stock was sold at an average price of $34.39, for a total value of $23,557.15. As a result of the transaction, the COO now directly owns 430,074 shares of the company, …

Fulgent Genetics, Inc. (NASDAQ: FLGT) COO sells $23,557.15 in stock Read More »

DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Fulgent Genetics, Inc. Securities Fraud Class Action

Final Deadline: Kessler Topaz Meltzer & Check, LLP reminds investors of lead plaintiff’s deadline in a securities fraud class action lawsuit filed against Fulgent Genetics, Inc. (FLGT)

RADNOR, Pa., Nov. 20, 2022 (GLOBE NEWSWIRE) — The law firm Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is advising investors that a securities class action lawsuit has been filed in the District United States Court for the Central District of California v. Fulgent Genetics, Inc. (“Fulgent”) (NASDAQ: FLGT). The suit accuses Fulgent of violations …

Final Deadline: Kessler Topaz Meltzer & Check, LLP reminds investors of lead plaintiff’s deadline in a securities fraud class action lawsuit filed against Fulgent Genetics, Inc. (FLGT) Read More »

Simply Wall St

What does the future hold for Fulgent Genetics, Inc. (NASDAQ: FLGT)? These analysts have reduced their estimates

Analysts covering Fulgent Genetics, Inc. (NASDAQ:FLGT) sent a dose of negativity to shareholders today, by making a substantial revision to their statutory guidance for next year. Earnings estimates were cut sharply as analysts signaled a weaker outlook – perhaps a sign that investors should also temper their expectations. The stock price rose 6.7% to US$37.02 …

What does the future hold for Fulgent Genetics, Inc. (NASDAQ: FLGT)? These analysts have reduced their estimates Read More »

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors with Losses to Get Counsel Ahead of Important Nov. 21 Deadline in Securities Class Action - FLGT

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors with Losses to Get Counsel Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT

NEW YORK, November 12, 2022 /PRNewswire/ — WHY: New York, November 12, 2022. Rosen Law Firm, a global investor rights law firm, reminds buyers of Fulgent Genetics, Inc. (NASDAQ: FLGT) securities between March 22, 2019 and August 4, 2022both dates included (the “Class Period”), of the material November 21, 2022 lead applicant deadline. SO WHAT: …

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fulgent Genetics, Inc. Investors with Losses to Get Counsel Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT Read More »

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action - FLGT

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), the important Deadline of November 21, 2022 for the main applicant. SO WHAT: …

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT Read More »

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action - FLGT

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Class Period”), the important Deadline of November 21, 2022 for the main applicant. SO WHAT: …

ROSEN, A TOP-TIER LAW FIRM, Encourages Fulgent Genetics, Inc. Investors to Seek Advice Ahead of Important Nov. 21 Deadline in Securities Class Action – FLGT Read More »